clinical status                            compound name      trademark marine organism α                               chemical class                            molecular target clinical trials β                disease area
0   fda - approved                     cytarabine (ara - c)  cytosar - u ®            sponge                                   nucleoside                              dna polymerase         >50 / 711                      cancer
1   fda - approved                     vidarabine (ara - a)     vira - a ®            sponge                                   nucleoside                        viral dna polymerase                 0                   antiviral
2   fda - approved                               ziconotide       prialt ®        cone snail                                      peptide                     n - type ca 2 + channel             2 / 5                   analgesic
3   fda - approved                eribulin mesylate (e7389)      halaven ®            sponge                                    macrolide                               s microtubule           19 / 27                      cancer
4   fda - approved      omega - 3 - fatty acid ethyl esters       lovaza ®              fish                        omega - 3 fatty acids         triglyceride - synthesizing enzymes           45 / 94        hypertriglyceridemia
5   fda - approved  trabectedin (et - 743) eu approved only     yondelis ®          tunicate                                     alkaloid                         minor groove of dna           17 / 34                      cancer
6        phase iii           brentuximab vedotin (sgn - 35)     adcetris ®           mollusk  antibody - drug conjugate (mm auristatin e)                       cd30 and microtubules            9 / 19                      cancer
7        phase iii                              plitidepsin      aplidin ®          tunicate                                 depsipeptide                     rac1 and jnk activation             1 / 7                      cancer
8         phase ii                         dmxba (gts - 21)          n / a              worm                                     alkaloid  alpha - 7 nicotinic acetylcholine receptor             0 / 3  congnition , schizophrenia
9         phase ii                    plinabulin (npi 2358)          n / a            fungus                             diketopiperazine         microtubules and jnk stress protein             1 / 2                      cancer
10        phase ii                              elisidepsin      irvalec ®           mollusk                                 depsipeptide                    plasma membrane fluidity             1 / 2                      cancer
11        phase ii                                  pm00104     zalypsis ®        nudibranch                                     alkaloid                               dna - binding             2 / 3                      cancer
12        phase ii        glembatumumab vedotin (cdx - 011)          n / a           mollusk    antibody drug conjugate (mm auristatin e)           glycoprotein nmb and microtubules             1 / 3                      cancer
13         phase i            marizomib (salinosporamide a)          n / a         bacterium                beta - lactone - gamma lactam                              20s proteasome             4 / 4                      cancer
14         phase i                                  pm01183          n / a          tunicate                                     alkaloid                         minor groove of dna             n / a                      cancer
15         phase i                                 sgn - 75          n / a           mollusk    antibody drug conjugate (mm auristatin f)                       cd70 and microtubules             2 / 2                      cancer
16         phase i                               asg - 5 me          n / a           mollusk    antibody drug conjugate (mm auristatin e)                    asg - 5 and microtubules             2 / 2                      cancer
17         phase i                     hemiasterlin (e7974)          n / a            sponge                                   tripeptide                                microtubules             0 / 3                      cancer
18         phase i                             bryostatin 1          n / a           bryozoa                                   polyketide                            protein kinase c            0 / 38         cancer , alzheimers

Table as JSON:
{"clinical status":{"0":"fda - approved","1":"fda - approved","2":"fda - approved","3":"fda - approved","4":"fda - approved","5":"fda - approved","6":"phase iii","7":"phase iii","8":"phase ii","9":"phase ii","10":"phase ii","11":"phase ii","12":"phase ii","13":"phase i","14":"phase i","15":"phase i","16":"phase i","17":"phase i","18":"phase i"},"compound name":{"0":"cytarabine (ara - c)","1":"vidarabine (ara - a)","2":"ziconotide","3":"eribulin mesylate (e7389)","4":"omega - 3 - fatty acid ethyl esters","5":"trabectedin (et - 743) eu approved only","6":"brentuximab vedotin (sgn - 35)","7":"plitidepsin","8":"dmxba (gts - 21)","9":"plinabulin (npi 2358)","10":"elisidepsin","11":"pm00104","12":"glembatumumab vedotin (cdx - 011)","13":"marizomib (salinosporamide a)","14":"pm01183","15":"sgn - 75","16":"asg - 5 me","17":"hemiasterlin (e7974)","18":"bryostatin 1"},"trademark":{"0":"cytosar - u ®","1":"vira - a ®","2":"prialt ®","3":"halaven ®","4":"lovaza ®","5":"yondelis ®","6":"adcetris ®","7":"aplidin ®","8":"n \/ a","9":"n \/ a","10":"irvalec ®","11":"zalypsis ®","12":"n \/ a","13":"n \/ a","14":"n \/ a","15":"n \/ a","16":"n \/ a","17":"n \/ a","18":"n \/ a"},"marine organism α":{"0":"sponge","1":"sponge","2":"cone snail","3":"sponge","4":"fish","5":"tunicate","6":"mollusk","7":"tunicate","8":"worm","9":"fungus","10":"mollusk","11":"nudibranch","12":"mollusk","13":"bacterium","14":"tunicate","15":"mollusk","16":"mollusk","17":"sponge","18":"bryozoa"},"chemical class":{"0":"nucleoside","1":"nucleoside","2":"peptide","3":"macrolide","4":"omega - 3 fatty acids","5":"alkaloid","6":"antibody - drug conjugate (mm auristatin e)","7":"depsipeptide","8":"alkaloid","9":"diketopiperazine","10":"depsipeptide","11":"alkaloid","12":"antibody drug conjugate (mm auristatin e)","13":"beta - lactone - gamma lactam","14":"alkaloid","15":"antibody drug conjugate (mm auristatin f)","16":"antibody drug conjugate (mm auristatin e)","17":"tripeptide","18":"polyketide"},"molecular target":{"0":"dna polymerase","1":"viral dna polymerase","2":"n - type ca 2 + channel","3":"s microtubule","4":"triglyceride - synthesizing enzymes","5":"minor groove of dna","6":"cd30 and microtubules","7":"rac1 and jnk activation","8":"alpha - 7 nicotinic acetylcholine receptor","9":"microtubules and jnk stress protein","10":"plasma membrane fluidity","11":"dna - binding","12":"glycoprotein nmb and microtubules","13":"20s proteasome","14":"minor groove of dna","15":"cd70 and microtubules","16":"asg - 5 and microtubules","17":"microtubules","18":"protein kinase c"},"clinical trials β":{"0":">50 \/ 711","1":"0","2":"2 \/ 5","3":"19 \/ 27","4":"45 \/ 94","5":"17 \/ 34","6":"9 \/ 19","7":"1 \/ 7","8":"0 \/ 3","9":"1 \/ 2","10":"1 \/ 2","11":"2 \/ 3","12":"1 \/ 3","13":"4 \/ 4","14":"n \/ a","15":"2 \/ 2","16":"2 \/ 2","17":"0 \/ 3","18":"0 \/ 38"},"disease area":{"0":"cancer","1":"antiviral","2":"analgesic","3":"cancer","4":"hypertriglyceridemia","5":"cancer","6":"cancer","7":"cancer","8":"congnition , schizophrenia","9":"cancer","10":"cancer","11":"cancer","12":"cancer","13":"cancer","14":"cancer","15":"cancer","16":"cancer","17":"cancer","18":"cancer , alzheimers"}}